1-3 of 3
Pritsana Chomchan
Close
Sort by
Journal Articles

Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell Lymphoma

Robert W. Chen, MD, Joycelynne M. Palmer, PhD, Leslie Popplewell**, MD, Jessica Alluin, Pritsana Chomchan, Auayporn P. Nademanee, MDBS, Tanya Siddiqi, MD, Nicole Tsai, Fay Zuo, Rosie Abary, Ji-lian Cai, Steven T. Rosen, MD, Stephen J. Forman, MD FACP, Larry W Kwak, MDPhD, Leona Holmberg, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4515.
https://doi.org/10.1182/blood.V130.Suppl_1.4515.4515
Published: 2017
Journal Articles

Interim Analysis of a Phase 2 Study of Bortezomib Plus Rituximab Maintenance Therapy in Patients with Mantle Cell Lymphoma Status Post Autologous Stem Cell Transplantation

Robert Chen, Joycelynne Palmer, PhD, Leona Holmberg, Jessica Alluin, Pritsana Chomchan, PhD, Leslie L. Popplewell, MD, Tanya Siddiqi, MD, Sandra H. Thomas, PhD, Kathryn Irenze, Auayporn P. Nademanee, MD, Ricardo Spielberger, MD, John J Rossi, Steven T. Rosen, MD, Larry W. Kwak, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2015) 126 (23): 1961.
https://doi.org/10.1182/blood.V126.23.1961.1961
Published: 2015
Journal Articles

BAFF-R Aptamer/STAT3 siRNA Construct Selectively Downregulates STAT3 mRNA in BAFF-R Expressing Lymphomas in Vitro and in Vivo

Robert W. Chen, MD, Pritsana Chomchan, PhD, Deepti Chadalavada, BS, Jessica Alluin, BS, jie-Hua Zhou, PhD, Stephen J. Forman, MD, John Rossi, PhD
Journal: Blood
Blood (2012) 120 (21): 65.
https://doi.org/10.1182/blood.V120.21.65.65
Published: 2012